Fig. 3From: Imaging with non-FDG PET tracers: outlook for current clinical applications11C-Methionine PET in two different patients previously operated on for glioma: (a) residual disease at the level of the surgical crater; (b) glioma recurrence in the contralateral brain hemisphereBack to article page